BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Treglia G, Mattoli MV, Bertagna F, Giubbini R, Giordano A. Emerging role of Fluorine-18-fluorodeoxyglucose positron emission tomography in patients with retroperitoneal fibrosis: a systematic review. Rheumatol Int 2013;33:549-55. [PMID: 23124736 DOI: 10.1007/s00296-012-2576-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Treglia G, Albano D, Dondi F, Bertagna F, Gheysens O. A Role of [18F]FDG PET/CT for Response Assessment in Large Vessel Disease? Semin Nucl Med 2022:S0001-2998(22)00070-8. [PMID: 36075772 DOI: 10.1053/j.semnuclmed.2022.08.002] [Reference Citation Analysis]
2 Casali M, Lauri C, Altini C, Bertagna F, Cassarino G, Cistaro A, Erba AP, Ferrari C, Mainolfi CG, Palucci A, Prandini N, Baldari S, Bartoli F, Bartolomei M, D'Antonio A, Dondi F, Gandolfo P, Giordano A, Laudicella R, Massollo M, Nieri A, Piccardo A, Vendramin L, Muratore F, Lavelli V, Albano D, Burroni L, Cuocolo A, Evangelista L, Lazzeri E, Quartuccio N, Rossi B, Rubini G, Sollini M, Versari A, Signore A. State of the art of 18F-FDG PET/CT application in inflammation and infection: a guide for image acquisition and interpretation. Clin Transl Imaging 2021;9:299-339. [PMID: 34277510 DOI: 10.1007/s40336-021-00445-w] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 12.0] [Reference Citation Analysis]
3 Tatoglu MT, Uslu H, Ibisoglu E. The value of (18)F-FDG PET/CT in Diagnosis and Evaluation of Response to Treatment in Retroperitoneal Fibrosis. Nuklearmedizin 2021. [PMID: 33836552 DOI: 10.1055/a-1429-2237] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Grozdic Milojevic IT, Milojevic B, Sobic-Saranovic DP, Artiko VM. Impact of hybrid molecular imaging in retroperitoneal fibrosis: a systematic review. Rheumatol Int 2018;38:179-87. [PMID: 28840309 DOI: 10.1007/s00296-017-3798-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
5 Wang Y, Guan Z, Gao D, Luo G, Li K, Zhao Y, Wang X, Zhang J, Jin J, Zhao Z, Yang C, Zhang J, Zhu J, Huang F. The value of 18F-FDG PET/CT in the distinction between retroperitoneal fibrosis and its malignant mimics. Semin Arthritis Rheum 2018;47:593-600. [PMID: 28958769 DOI: 10.1016/j.semarthrit.2017.07.011] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
6 Brandt AS, Dreger NM, Müller E, Kukuk S, Roth S. Neue (und alte) Aspekte der retroperitonealen Fibrose. Urologe 2017;56:887-94. [DOI: 10.1007/s00120-017-0428-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
7 Fernando A, Pattison J, Horsfield C, D’cruz D, Cook G, O’brien T. [ 18 F]-Fluorodeoxyglucose Positron Emission Tomography in the Diagnosis, Treatment Stratification, and Monitoring of Patients with Retroperitoneal Fibrosis: A Prospective Clinical Study. European Urology 2017;71:926-33. [DOI: 10.1016/j.eururo.2016.10.046] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 4.8] [Reference Citation Analysis]
8 Brandt AS, Kukuk S, Dreger NM, Müller E, Roth S. Diagnostik und Therapie der retroperitonealen Fibrose. Urologe 2016;55:732-40. [DOI: 10.1007/s00120-016-0081-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
9 Shiber S, Eliakim-raz N, Yair M. Fibrose retroperitoneal: série de cinco casos e revisão da literatura. Revista Brasileira de Reumatologia 2016;56:101-4. [DOI: 10.1016/j.rbr.2014.09.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
10 Lioger B, Yahiaoui Y, Kahn JE, Fakhouri F, Belenfant X, Papo T, Magnant J, Maillot F, Vordos D, Godeau B, Michel M. [Retroperitoneal fibrosis in adults: Main characteristics and relevance of the diagnostic procedures based on a retrospective multicenter study on 77 cases]. Rev Med Interne 2016;37:387-93. [PMID: 26415922 DOI: 10.1016/j.revmed.2015.08.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
11 Shiber S, Eliakim-Raz N, Yair M. Retroperitoneal fibrosis: case series of five patients and review of the literature. Rev Bras Reumatol Engl Ed 2016;56:101-4. [PMID: 27267521 DOI: 10.1016/j.rbre.2014.09.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.1] [Reference Citation Analysis]
12 Peixoto RD, Al-Barrak J, Lim H, Renouf D. Gastroesophageal cancer and retroperitoneal fibrosis: Two case reports and review of the literature. World J Gastrointest Oncol 2013; 5(3): 68-70 [PMID: 23671733 DOI: 10.4251/wjgo.v5.i3.68] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]